ASPG and acute lymphoblastic leukemia: A global pediatric phase IB/II trial of carfilzomib combined with vincristine, dexamethasone, asparaginase, and daunorubicin (VXLD) as a reinduction therapy for children with R/R ALL has been recently completed (NCT02303821).